Medtronic Analyst Turns Bullish; Top 5 Upgrades for Tuesday
Tuesday, Mar 4, 2025 9:43 am ET
2min read Medtronic, a leading medical device company, has seen a surge in analyst optimism, with several top firms upgrading their ratings and price targets. This positive sentiment is driven by the company's strong financial performance, innovative product pipeline, and expansion into high-growth markets. Here are the top 5 upgrades for Tuesday, highlighting the key factors that have analysts bullish on medtronic.
1. citigroup Upgrades Medtronic to 'Buy'
Citigroup analyst Joanne Wuensch upgraded Medtronic's rating from 'Neutral' to 'Buy' and raised the price target from $92 to $107. This upgrade reflects the analyst's positive outlook on the company's growth prospects, driven by strong revenue growth, improved gross and operating margins, and positive outlooks on key business segments such as Cardiac Rhythm Management, Structural Heart, Diabetes, and Neuromodulation.
2. Barclays Upgrades HSBC to 'Overweight'
Barclays analyst Aman Rakkar upgraded HSBC Holdings plc's rating from 'Equal-Weight' to 'Overweight.' This upgrade is based on the analyst's positive outlook on the banking sector and HSBC's strong performance in the face of challenging market conditions.
Disclaimer: the above is a summary showing certain market information. AInvest is not responsible for any data errors, omissions or other information that may be displayed incorrectly as the data is derived from a third party source. Communications displaying market prices, data and other information available in this post are meant for informational purposes only and are not intended as an offer or solicitation for the purchase or sale of any security. Please do your own research when investing. All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit, or protect against loss in a down market.